These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23074998)

  • 41. The molecular mechanism of thrombospondin family members in cardiovascular diseases.
    Pan H; Lu X; Ye D; Feng Y; Wan J; Ye J
    Front Cardiovasc Med; 2024; 11():1337586. PubMed ID: 38516004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites.
    Stenina OI; Ustinov V; Krukovets I; Marinic T; Topol EJ; Plow EF
    FASEB J; 2005 Nov; 19(13):1893-5. PubMed ID: 16148025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.
    Fears CY; Grammer JR; Stewart JE; Annis DS; Mosher DF; Bornstein P; Gladson CL
    Cancer Res; 2005 Oct; 65(20):9338-46. PubMed ID: 16230396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin.
    Damber JE; Vallbo C; Albertsson P; Lennernäs B; Norrby K
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):354-60. PubMed ID: 16333676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombospondins as key regulators of synaptogenesis in the central nervous system.
    Risher WC; Eroglu C
    Matrix Biol; 2012 Apr; 31(3):170-7. PubMed ID: 22285841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
    Grainger DJ; Frow EK
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure of human thrombospondin: complete amino acid sequence derived from cDNA.
    Frazier WA; Dixit VM; Galvin NJ; Rotwein PR
    Semin Thromb Hemost; 1987 Jul; 13(3):255-60. PubMed ID: 3686018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombospondin in Tumor Microenvironment.
    Ramchandani D; Mittal V
    Adv Exp Med Biol; 2020; 1272():133-147. PubMed ID: 32845506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of a Thrombospondin Superfamily at the Origin of Metazoans.
    Shoemark DK; Ziegler B; Watanabe H; Strompen J; Tucker RP; Özbek S; Adams JC
    Mol Biol Evol; 2019 Jun; 36(6):1220-1238. PubMed ID: 30863851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombospondin-1 in drug activity and tumor response to therapies.
    Longhi E; Carminati L; Carlessi E; Belotti D; Taraboletti G
    Semin Cell Dev Biol; 2024 Mar; 155(Pt B):45-51. PubMed ID: 37414720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Roles of Thrombospondins in Hemorrhagic Stroke.
    Wu X; Luo X; Zhu Q; Zhang J; Liu Y; Luo H; Cheng Y; Xie Z
    Biomed Res Int; 2017; 2017():8403184. PubMed ID: 29214179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of heart rate in the development of cardiovascular disease.
    Reil JC; Böhm M
    Clin Res Cardiol; 2007 Sep; 96(9):585-92. PubMed ID: 17593316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interaction of Thrombospondins with extracellular matrix proteins.
    Tan K; Lawler J
    J Cell Commun Signal; 2009 Dec; 3(3-4):177-87. PubMed ID: 19830595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphoinositides and cardiovascular diseases.
    Ghigo A; Perino A; Hirsch E
    Curr Top Microbiol Immunol; 2012; 362():43-60. PubMed ID: 23086412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolution of thrombospondins and their ligand-binding activities.
    Bentley AA; Adams JC
    Mol Biol Evol; 2010 Sep; 27(9):2187-97. PubMed ID: 20427418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix.
    Adams JC
    Int J Exp Pathol; 2024 Oct; 105(5):136-169. PubMed ID: 39267379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombospondins and remodeling of the tumor microenvironment.
    Stenina-Adognravi O; Muppala S; Gajeton J
    Vessel Plus; 2018; 2():. PubMed ID: 32984773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
    Raj P; Thandapilly SJ; Wigle J; Zieroth S; Netticadan T
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34771008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.